BioVentrixL Ralph Stephan von Bardeleben Signs On as Co- Principal Investigator of the REVIVE-HF Clinical Trial

Press/Media

Period12 Mar 2020

Media coverage

1

Media coverage

  • TitleBioVentrixL Ralph Stephan von Bardeleben Signs On as Co- Principal Investigator of the REVIVE-HF Clinical Trial
    Media name/outletWireless News(Close-up Media)
    Country/TerritoryUnited States
    Date12/03/20
    PersonsGregg Stone
View all 1
View less